R. Dornburg

发表

Spleen necrosis virus-derived C-type retroviral vectors for gene transfer to quiescent cells

Zahida Parveen, R. Pomerantz, K. Cichutek, 2000, Nature Biotechnology.

Presence of a retroviral encapsidation sequence in nonretroviral RNA increases the efficiency of formation of cDNA genes

H. Temin, R. Dornburg, 1990, Journal of virology.

Retroviral vector particles displaying the antigen-binding site of an antibody enable cell-type-specific gene transfer

R. Dornburg, T. Chu, T. T. Chu, 1995, Journal of virology.

Targeting human T cells by retroviral vectors displaying antibody domains selected from a phage display library.

R. Kurth, K. Cichutek, J. Stitz, 2000, Human gene therapy.

Spleen necrosis virus-based vector delivery of anti-HIV-1 genes potently protects human hematopoietic cells from HIV-1 infection.

E. Marusich, R. Pomerantz, D. Strayer, 2005, Virology.

Cross-Packaging of Human Immunodeficiency Virus Type 1 Vector RNA by Spleen Necrosis Virus Proteins: Construction of a New Generation of Spleen Necrosis Virus-Derived Retroviral Vectors

R. Pomerantz, Z. Parveen, R. Dornburg, 2004, Journal of Virology.

Cell-type-specific gene delivery into neuronal cells in vitro and in vivo.

R. Pomerantz, Z. Parveen, R. Dornburg, 2003, Virology.

Reticuloendotheliosis viruses and derived vectors for human gene therapy.

R. Dornburg, 2003, Frontiers in bioscience : a journal and virtual library.

Cell-Type-Specific Gene Transfer into Human Cells with Retroviral Vectors That Display Single-Chain Antibodies

K. Cichutek, R. Dornburg, F. Nocken, 1998, Journal of Virology.

Increase of cloning efficiencies by using high-performance liquid chromatography-purified vectors and linkers.

P. Hofschneider, R. Dornburg, P. Földi, 1984, Journal of chromatography.

In vivo cell type-specific gene delivery with retroviral vectors that display single chain antibodies

R. Dornburg, A. Jiang, 1999, Gene Therapy.

cDNA genes formed after infection with retroviral vector particles lack the hallmarks of natural processed pseudogenes

H. Temin, R. Dornburg, 1990, Molecular and cellular biology.

Retroviral packaging cells encapsulated in TheraCyte immunoisolation devices enable long-term in vivo gene delivery.

E. Marusich, Z. Parveen, Anna Krupetsky, 2003, Frontiers in bioscience : a journal and virtual library.

Toward highly efficient cell-type-specific gene transfer with retroviral vectors displaying single-chain antibodies

R. Dornburg, T. Chu, T. T. Chu, 1997, Journal of virology.

Partial reconstitution of a replication-competent retrovirus in helper cells with partial overlaps between vector and helper cell genomes.

R. Dornburg, I. Martinez, 1996, Human gene therapy.

Retroviral vector system for the study of cDNA gene formation

H. Temin, R. Dornburg, 1988, Molecular and cellular biology.

Gene Therapy for HIV-1 Infection

R. Pomerantz, R. Dornburg, 2002 .

A genetically engineered spleen necrosis virus-derived retroviral vector that displays the HIV type 1 glycoprotein 120 envelope peptide.

R. Pomerantz, R. Dornburg, H. Fisher, 1999, Human gene therapy.

Mutational analysis of the envelope protein of spleen necrosis virus

R. Dornburg, I. Martinez, 1996, Journal of virology.

Mapping of receptor binding domains in the envelope protein of spleen necrosis virus

R. Dornburg, I. Martinez, 1995, Journal of virology.

Spliced spleen necrosis virus vector RNA is not encapsidated: implications for retroviral replication and vector design.

R. Pomerantz, Z. Parveen, R. Dornburg, 2004, Molecular therapy : the journal of the American Society of Gene Therapy.

Avian Reticuloendotheliosis Virus Strain A and Spleen Necrosis Virus Do Not Infect Human Cells

R. Dornburg, T. Jaffredo, R. Gautier, 2000, Journal of Virology.

The history and principles of retroviral vectors.

R. Dornburg, 2003, Frontiers in bioscience : a journal and virtual library.

Improved self-inactivating retroviral vectors derived from spleen necrosis virus

R. Dornburg, S. Nelson, P. Olson, 1994, Journal of virology.

Unusually high frequency of reconstitution of long terminal repeats in U3-minus retrovirus vectors by DNA recombination or gene conversion

H. Temin, R. Dornburg, P. Olson, 1992, Journal of virology.

Replication of lentiviruses.

R. Pomerantz, R. Dornburg, E. Acheampong, 2003, Frontiers in bioscience : a journal and virtual library.

Capture of a recombination activating sequence from mammalian cells

R. Dornburg, P. Olson, 1999, Gene Therapy.

Gene Therapy and HIV-1 Infection

R. Pomerantz, R. Dornburg, 2002 .

HIV-1 gene therapy: promise for the future.

R. Pomerantz, R. Dornburg, 2000, Advances in pharmacology.

Reticuloendotheliosis virus-derived vectors for human gene therapy

R. Dornburg, 2004 .

Do Retroviruses Contribute to the Genesis of Intron-Less Pseudogenes?

H. Temin, R. Dornburg, 1989 .

Improved retroviral packaging lines derived from spleen necrosis virus.

R. Dornburg, I. Martinez, 1995, Virology.

Cell targeting with retroviral vector particles containing antibody-envelope fusion proteins.

R. Dornburg, W. Sheay, T. Chu, 1994, Gene therapy.

From the natural evolution to the genetic manipulation of the host-range of retroviruses.

R. Dornburg, 1997, Biological chemistry.

Downstream insertion of the adenovirus tripartite leader sequence enhances expression in universal eukaryotic vectors.

R. Dornburg, S. Bhatia, W. Sheay, 1993, BioTechniques.

Reticuloendotheliosis viruses and derived vectors.

R. Dornburg, 1995, Gene therapy.

Unusually HighFrequency ofReconstitution ofLongTerminal Repeats inU3-Minus Retrovirus Vectors byDNA Recombination orGeneConversion

H. Temin, R. Dornburg, P. Olson, 1992 .

Highly efficient eukaryotic gene expression vectors for peptide secretion.

R. Dornburg, T. Chu, I. Martinez, 1995, BioTechniques.

Highly efficient eukaryotic gene expression vectors for peptide secretion.

R. Dornburg, T. Chu, I. Martinez, 1995, Peptide research.